권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Benzeno S, Diehl JA. C-terminal sequence direct cyclin D1-CRM1 binding. J Biol Chem. 1999. 279: 56061-56066. | 미소장 |
| 2 | Treatment of non-small-cell lung cancer with erlotinib or gefitinib. ![]() |
미소장 |
| 3 | The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. ![]() |
미소장 |
| 4 | Chang GC, Hsu SL, Tsai JR, Liang FP, Lin SY, Sheu GT, Chen CY. Molecular mechanism of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells. Biochem Pharm. 2004. 68: 1453-1464. | 미소장 |
| 5 | CDK inhibitors: positive and negative regulators of G1-phase progression. ![]() |
미소장 |
| 6 | The p21^C^i^p^1 and p27^K^i^p^1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts ![]() |
미소장 |
| 7 | Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure ![]() |
미소장 |
| 8 | Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR, Tortora G. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptorselective tyrosine kinase inhibitor. Clin Cancer Res. 2000. 6: 2053-2063. | 미소장 |
| 9 | Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. ![]() |
미소장 |
| 10 | Interaction among GSK-3, GBP, Axin, and APC in Xenopus Axis Specification ![]() |
미소장 |
| 11 | Targeting multiple kinase pathways: a change in paradigm. ![]() |
미소장 |
| 12 | Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells. ![]() |
미소장 |
| 13 | Cancer Statistics, 2003 ![]() |
미소장 |
| 14 | New functional activities for the p21 family of CDK inhibitors. ![]() |
미소장 |
| 15 | Epidermal growth factor receptor: a promising target in solid tumours ![]() |
미소장 |
| 16 | Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells | 소장 |
| 17 | Lee EJ, Whang, JH, Jeon, NK, Kim J. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses proliferation and invasion of human oral squamous carcinoma cells via p53 independent and MMP, uPAR dependent mechanism. Annals NYAS. 2007. 1095: 113-128. | 미소장 |
| 18 | Transactivation and expression patterns of Jun and Fos/AP‐1 super‐family proteins in human oral cancer ![]() |
미소장 |
| 19 | Glycogen synthase kinase 3 beta: can it be a target for oral cancer ![]() |
미소장 |
| 20 | Dysregulated molecular networks in head and neck carcinogenesis ![]() |
미소장 |
| 21 | Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MAPK activation is dependent on constitutive epidermal growth factor receptor activation. ![]() |
미소장 |
| 22 | Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. ![]() |
미소장 |
| 23 | Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. ![]() |
미소장 |
| 24 | Sgambato A, Camerini A, Faraglia B, Ardito R, Bianchino G, Spada D, Boninsegna A, Valentini V, Cittadini A. Targeted inhibition of the epidermal growth factor receptor-tyrosin kinase by ZD1839 ('Iressa') induces cell-cycle arrest and inhibits proliferation in prostate cancer cells. J Cell Physio. 2004. 201: 97-105. | 미소장 |
| 25 | Shintani S, Li C, Mihara M, Yano J, Terakado N, Nakashiro K, Hamakawa H. Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines. Oral Oncology. 2004. 40: 43-51. | 미소장 |
| 26 | Molecular correlates of gefitinib responsiveness in human bladder cancer cells. ![]() |
미소장 |
| 27 | Sirotnak FM. Studies with ZD1839 in preclinical model. Semin Oncol. 2003. 1: 12-20. | 미소장 |
| 28 | Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity ![]() |
미소장 |
| 29 | Clinical pharmacokinetics of tyrosine kinase inhibitors ![]() |
미소장 |
| 30 | Wakeling AE, Guy SP, Woodburn JR, Ashton SE, Curry BJ, Barker AJ, Gibson KH. ZD1839 (Iressa): an orally activive inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res. 2002. 62: 5749-5754. | 미소장 |
| 31 | Zhang Z, Wang H, Li M, Agrawal S, Chen X, Zhang R. MDM2 is a negative regulator of p21WAF1/CIP1,independent of p53. J Bio Chem. 2004. 16: 16000-16006. | 미소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.